
Tocilizumab, Alone or With Methotrexate, Potent in Active RA
TOPLINE: Subcutaneous tocilizumab, either as monotherapy or in combination with methotrexate, demonstrated greater efficacy than methotrexate alone and was well tolerated in patients with active rheumatoid arthritis (RA) who had an inadequate response to …